logoslogan

ANNUAL MEETING 2019

Near-peak abstract submissions for Vienna

ESHRE 2019 promises another feast of science with 1854 abstract submissions, a hot invited programme now in place, and 16 precongress courses.

IN PROFILE: ARNE SUNDE

A new editor-in-chief for Human Reproduction Update

Next year the Norwegian embryologist Arne Sunde will take over as editor-in-chief of ESHRE's remarkably successful review journal Human Reproduction Update, whose impact factor reached 11.85 at the last assessment. Sunde's experience with ESHRE reaches back to the very first Executive Committee assembled by Robert Edwards in 1984.

CANCER RISK

Cancer risk and its association with infertility

Despite short follow-up period and a low absolute risk, insurance-claim study finds infertile women at significantly higher risk of several cancers than controls

RECURRENT PREGNANCY LOSS

Commonly used preventive therapy for recurrent miscarriage proved ineffective in large trial

Recombinant human granulocyte-colony stimulating factor (rhG-CSF) administered in the first trimester of pregnancy fails to increase the chance of a live birth for women with unexplained recurrent pregnancy loss.

ANNUAL MEETING 2019

Highlights from the scientific programme

Thomas Ebner from the local organising committee of this year's Annual Meeting in Vienna previews its programme, noting that the opening keynote lectures are likely to be heard by an audience of more than 4000 delegates.

CHAIRMAN'S UPDATE

More responsive and more effective

ESHRE Chairman Roy Farquharson describes the outcome of a two-year strategic review which aims to enhance member support in five key areas of ESHRE activity.

MIRACLE TWINS

First prenatal detection of semi-identical twins

A case report of children conceived from one egg and two sperm cells who are neither identical nor fraternal twins - but fit 'somewhere in between'

ELECTIVE FET

The number of freeze-all cycles in IVF continues to increase 'dramatically'

As another meta-analysis finds only limited outcome benefit from frozen embryo transfers, US data indicate that 25% of all cycles in 2016 were freeze-all.

Stem Cells

SIG STEM CELLS

Two decades in embryonic stem cells

Cristina Eguizabal, Co-ordinator of ESHRE's SIG Stem Cells, looks back from the twentieth anniversary of the derivation of the first human embryonic stem cells.

FREEZE ALL UPDATE

Improved IVF birth rates following deferred blastocyst transfer

Results described as 'practice-changing', as large Chinese trial finds freeze-all transfers associated with higher live birth rates than fresh in good prognosis ovulatory patients.